Literature DB >> 26426250

Next-Generation Sequencing for the Identification of Targetable Molecular Alterations in Cancer.

Martin F Dietrich1, Robert H Collins1, David E Gerber1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26426250     DOI： 10.1001/jamaoncol.2015.3788

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  2 in total

1.  Going into BATTLE: umbrella and basket clinical trials to accelerate the study of biomarker-based therapies.

Authors:  Sawsan Rashdan; David E Gerber
Journal:  Ann Transl Med       Date:  2016-12

2.  Accessing Targeted Therapies: A Potential Roadblock to Implementing Precision Oncology?

Authors:  Mitchell S von Itzstein; Mary L Smith; Elda Railey; Carol B White; Julianne S Dieterich; Liz Garrett-Mayer; Suanna S Bruinooge; Andrew N Freedman; Janet De Moor; Stacy W Gray; Jason Y Park; Jingsheng Yan; Anh Quynh Hoang; Hong Zhu; David E Gerber
Journal:  JCO Oncol Pract       Date:  2021-05-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.